Avidity Biosciences Honors Rare Disease Day®

SAN DIEGO, Feb. 28, 2022 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™),?today announced its support for Rare Disease Day® and highlights the…

Click here to view original post